In Her Own Words: Olaris founder Dr. Elizabeth O’Day’s biopharma company was at the crossroads of performance and pandemic
Dr. Elizabeth O’Day’s Olaris team had developed a platform that could help patients suffering from breast cancer and Parkinson’s as well as other diseases get the right drugs at the right time. And then Covid-19 hit. Read more in The Business Journals feature.
September 1, 2020